RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+17.81%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.3B
AUM Growth
+$5.3B
Cap. Flow
+$279M
Cap. Flow %
5.26%
Top 10 Hldgs %
58.3%
Holding
63
New
4
Increased
10
Reduced
3
Closed
9

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$381M
2
LEGN icon
Legend Biotech
LEGN
$264M
3
AXSM icon
Axsome Therapeutics
AXSM
$71.9M
4
NAMS icon
NewAmsterdam Pharma
NAMS
$59.5M
5
FDMT icon
4D Molecular Therapeutics
FDMT
$55.5M

Top Sells

1
IMGN
Immunogen Inc
IMGN
$368M
2
BLU
BELLUS Health Inc.
BLU
$91M
3
CLDX icon
Celldex Therapeutics
CLDX
$62.4M
4
HLVX icon
HilleVax
HLVX
$29.1M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$26.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CNTB
51
Connect Biopharma Holdings Limited Ordinary Shares
CNTB
$111M
$7.9M 0.15%
6,991,003
– –
TRML icon
52
Tourmaline Bio
TRML
$645M
$7.09M 0.13%
+233,318
New +$7.09M
NSTG
53
DELISTED
NanoString Technologies, Inc.
NSTG
$6.98M 0.13%
1,723,373
-733,900
-30% -$2.97M
NAMSW icon
54
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
$697K 0.01%
333,333
– –
CLDX icon
55
Celldex Therapeutics
CLDX
$1.57B
– –
-1,734,972
Closed -$62.4M
ENTX icon
56
Entera Bio
ENTX
$92.7M
– –
-295,966
Closed -$343K
HLVX icon
57
HilleVax
HLVX
$105M
– –
-1,760,019
Closed -$29.1M
RCKT icon
58
Rocket Pharmaceuticals
RCKT
$358M
– –
-1,131,775
Closed -$19.4M
WHWK
59
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
– –
-590,218
Closed -$4.27M
FUSN
60
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-659,992
Closed -$2.49M
KNTE
61
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
– –
-4,264,144
Closed -$26.7M
BLU
62
DELISTED
BELLUS Health Inc.
BLU
– –
-12,643,574
Closed -$91M
STSA
63
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
– –
-5,914,252
Closed -$4.13M
1 2
3